P. Sun

Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties.

W. Sippl, C. Romier, M. Schutkowski, 2022, Journal of medicinal chemistry.

Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity

W. Sippl, C. Romier, M. Schutkowski, 2021, International journal of molecular sciences.

Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds

W. Sippl, M. Schutkowski, D. Robaa, 2023, Pharmaceuticals.